Technical Analysis for DXCM - DexCom, Inc.

Grade Last Price % Change Price Change
grade A 163.68 3.25% 5.15
DXCM closed up 3.25 percent on Friday, August 16, 2019, on 1.24 times normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical DXCM trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
New 52 Week High Strength 0.00%
Stochastic Reached Overbought Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish 3.25%
20 DMA Support Bullish 6.63%

Older signals for DXCM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments. The company's in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. It also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. The company markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Medicine Diabetes Healthcare Providers Endocrine System Diabetes Mellitus Medical Monitoring Endocrinology Software Platform Blood Glucose Monitoring Continuous Glucose Monitor Hyperglycemia Hypoglycemia
Is DXCM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 165.09
52 Week Low 105.05
Average Volume 1,054,088
200-Day Moving Average 134.8076
50-Day Moving Average 149.5652
20-Day Moving Average 152.814
10-Day Moving Average 153.167
Average True Range 5.8816
ADX 15.86
+DI 33.8332
-DI 16.6807
Chandelier Exit (Long, 3 ATRs ) 147.4452
Chandelier Exit (Short, 3 ATRs ) 157.1748
Upper Bollinger Band 162.6602
Lower Bollinger Band 142.9678
Percent B (%b) 1.05
BandWidth 12.886516
MACD Line 2.7709
MACD Signal Line 1.9299
MACD Histogram 0.841
Fundamentals Value
Market Cap 14.18 Billion
Num Shares 86.6 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -215.37
Price-to-Sales 6.08
Price-to-Book 10.87
PEG Ratio -1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 173.51
Resistance 3 (R3) 172.88 168.99 171.87
Resistance 2 (R2) 168.99 166.48 169.30 171.32
Resistance 1 (R1) 166.33 164.94 167.66 166.96 170.78
Pivot Point 162.44 162.44 163.10 162.75 162.44
Support 1 (S1) 159.78 159.93 161.11 160.41 156.58
Support 2 (S2) 155.89 158.39 156.20 156.04
Support 3 (S3) 153.23 155.89 155.49
Support 4 (S4) 153.86